Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children
- 675 Downloads
For the comparison of long-term outcome of the management of medical or surgical treatment of children with severe vesicoureteral reflux (VUR), children aged <11 years with non-obstructive grade III/IV reflux, previous urinary tract infection (UTI) and glomerular filtration rate (GFR) ≥70 ml/min per 1.73 m2 body surface area were recruited, and 306 were randomly allocated to receive antimicrobial prophylaxis or ureteral reimplantation. Primary endpoints were new renal scars and renal growth. Follow up, originally planned for 5 years, was extended to 10 years for 252 children, 223 of whom had follow-up imaging. Up to 5 years, 40 new urographic scars (medical 19, surgical 21) were seen. Between 5 years and 10 years, only two further scars were observed. Renal growth and UTI recurrence rate were similar, except that medically treated patients had more febrile infections. There was no difference in somatic growth, radionuclide imaging or renal function. A GFR <70 ml/min per 1.73 m2 was found in only one patient. Three patients developed hypertension requiring treatment. We conclude that, with close supervision and prompt treatment of recurrences, children entering the study with GFR ≥70 ml/min per 1.73 m2 progressed remarkably well under either medical or surgical management, emphasizing the importance of continued supervision and the entry level of renal function.
KeywordsUrinary tract infection Urography Renal scar Renal function Hypertension Kidney growth DMSA scan
This study was supported by the VW Foundation (grants AZ 35 807 and AZ I/37 504) and by the German Government (Bundesministerium für Forschung und Technologie, grant 07068343; Bundesministerium für Wissenschaft und Forschung, grants 07 06570/0 GFF and 01 EP 95084/4 DLR).
- 1.International Reflux Study Committee (1981) Medical versus surgical treatment of primary vesicoureteral reflux. Pediatrics 67:392–400Google Scholar
- 3.Weiss R, Tamminen-Möbius T, Koskimies O, Olbing H, Smellie JM, Hirche H, Lax-Gross (1992) Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. J Urol 148:1644–1649CrossRefGoogle Scholar
- 11.Piepsz A, Tamminen-Möbius T, Reiners C, Heikkila J, Kivisaari A, Nilsson NJ, Sixt R, Risdon RA, Smellie JM, Söderborg B (1998) Five-year study of medical or surgical treatment in children with severe vesico-ureteral reflux: dimercaptosuccinic acid findings. Eur J Pediatr 157:753–758CrossRefGoogle Scholar
- 12.Wingen AM, Koskimies O, Olbing H, Seppänen J, Tamminen-Möbius T (1999) Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10-year results of a prospective, randomized study. The International Reflux Study in Children (European Branch). Acta Paediatr 88:56–61CrossRefGoogle Scholar
- 13.Olbing H, Hirche H, Koskimies O, Lax H, Seppänen U, Smellie JM, Tamminen-Möbius T, Wikstad I (2000) Renal growth in children with severe vesicoureteral reflux: 10-year prospective study of medical and surgical treatment. The International Reflux Study in Children (European Branch). Radiology 216:731–737CrossRefGoogle Scholar
- 23.Szlyk GR, Williams SB, Majd M, Belman AB, Rushton HG (2003) Incidence of new renal parenchymal inflammatory changes following breakthrough urinary tract infection in patients with vesicoureteral reflux treated with antibiotic prophylaxis: evaluation by 99mtechnetium dimercapto-succinic acid renal scan. J Urol 170:1566–1569CrossRefGoogle Scholar